JCNRJournal of Clinical and Nursing Research2208-36852208-3693Bio-Byword Scientific Publishing Pty. Ltd.10.26689/jcnr.v6i5.4301ArticleThe Level of Expression and Diagnostic Value of Biomarkers in Tuberculous Pleurisyhttps://artdesignp.com/journal/JCNR/6/5/10.26689/jcnr.v6i5.4301WangLin,QiYing,QiSuhong2022652022-09-30Objective: Observe and analyze the clinical significance of the differences in the expression levels of sCD163, haptoglobin and cytokines. Methods: 120 patients with tuberculous pleural effusion diagnosed in our hospital from January 2019 to December 2021 were randomly selected as the experimental group. On the other hand, 40 patients with non-tuberculous pleural effusion admitted in the same period were selected as the control group. The expression levels of sCD163, haptoglobin and cytokines were observed and analyzed. Results: The expression levels of sCD163 (?g/mL), haptoglobin (g/L), IL-6 (pg/mL) and IL-12 (pg/mL) of the control group were 31.26 ± 14.12, 32.14 ± 18.79, 401.23 ± 24.36 and 1.32 ± 0.14, respectively. As for the experimental group, the expression levels of sCD163 (?g/mL), haptoglobin (g/L), IL-6 (pg/mL) and IL-12 (pg/mL) were 74.12 ± 14.78, 113.25 ± 19.45, 612.12 ± 36.98 and 4.12 ± 0.56 respectively, and p < 0.05 which shows that the data was statistically significant. Conclusion: The level of inflammatory cytokines in the pleural fluid of tuberculous pleural effusion patients are higher, which can be used for the diagnosis of auxiliary tuberculous pleurisy. Tuberculous pleural effusion patients has a significantly increased expression levels of sCD163 and haptoglobin in the pleural fluid. The combination of sCD163 and haptoglobin in the diagnosis of tuberculous pleural effusion has higher clinical diagnostic value, and sCD163 and haptoglobin are not interfered by inflammatory factors in the diagnosis of tuberculous pleural effusion

Guo T, Yang B, Yang F, et al., 2021, Diagnostic Value of GeneXpert MTB/RIF in Tuberculous Pleurisy. Ningxia Medical Journal, 2021, 43(04): 343–345.

Deng A, Zhang G, Lai M, et al., 2021, Diagnostic Value of T Cell Spot Test in Pleural Effusion and Peripheral Blood Tuberculosis Infection in Tuberculous Pleural Effusion Chinese Contemporary Medicine, 28(06): 145–148.

Wu Y, Zhang L, 2021, LPS, IL-35, ROR in Pleural Fluid and Expression Changes in Tuberculous Pleural Effusion and Clinical Significance. International Journal of Respiration, 41(03): 172–177.

Zhang X, Zhang Y, Yao C, et al., 2020, The Value of Tuberculosis Infected T Cell Spot Test Combined with Pleural Effusion GeneXpert MTB/RIF in the Diagnosis of Tuberculous Pleural Effusion. Guangdong Medicine, 41(24): 2564–2568.

Peng D, Chen G, Tong K, et al., 2020, Study on the Value of Combined Detection of Serum ADA, IL-27 and TB AB in the Diagnosis of Bloody Tuberculous Pleural Effusion. Chinese Journal of Modern Medicine, 30(22): 91–94.

Cha L, Zhang L, Pan H, et al., 2020, Clinical Value of ADA And LDH in the Diagnosis of Tuberculous and Bacterial Pleural Effusion. Clinical Research, 28(11): 12–14.

Chen X, Hou W, 2020, Expression and Clinical Significance of Interferon- T and Interleukin-10 in Pulmonary Tuberculosis Serum, Alveolar Lavage Fluid and Tuberculous Pleural Effusion. Journal of Practical Hospital Clinical, 17(04): 139–143.

Wu Y, 2020, The Application Value of The Ratio of Carcinoembryonic Antigen to Serum Carcinoembryonic Antigen in Pleural Effusion and the Secreted Phosphoprotein 1 in Pleural Effusion In Differentiating Tuberculous Pleural Effusion From Pleural Effusion Caused by Lung Cancer Guangxi Medicine, 42(12): 1503–1506.

Yang Z, 2020, Significance Of VCAM-1 in the Diagnosis of Tuberculous Pleurisy, dissertation, Nanhua University.

Zhang Z, 2020, Diagnostic Value of Pleural Effusion ADA, Ada2 Combined with L/N in Tuberculous Pleurisy, dissertation, Hunan Normal University.

Liu Y, Zhang S, Zhang J, et al., 2019, The Role of ? Interferon Release Test Combined with Biochemical Indicators in the Diagnosis of Tuberculous Pleural Effusion. China Tropical Medicine, 19(12): 1108–1112.

Cheng L, Chen H, Zhao Xi, et al., 2019, Expression Level and Clinical Significance of IL-27 in Tuberculous Pleural Effusion. International Journal of Respiration, 2019(23):1795–1799.

Liang L, Li X, Xiao Q, et al., 2019, Discussion on C-O-P Tuberculous Pleural Effusion Scoring System Based on CA125, ADA and IL-27. Chinese And Foreign Medical Research, 17(33):1–8.

Tang T, Long M, Li J, et al., 2019, Levels of Interleukin-27, Interferon Gamma and Adenosine Deaminase in Pleural Fluid of Tuberculous Pleural Effusion and Their Clinical Significance. Journal of Practical Hospital Clinical, 16(06): 141–144.

Nong X, Huang J, Feng Y, et al., 2019, Application Value of Exosome ?-Actin mRNA in Differential Diagnosis of Malignant and Tuberculous Pleural Effusion. China Medical Innovation, 16(29): 168–172.

Liu J, 2019, Clinical Treatment Analysis of 306 Patients with Tuberculous Pleurisy. World Latest Medical Information Digest, 19(83): 109 + 113.

Chu Y, Yu Q, 2019, Research Progress in Diagnosis of Tuberculous Pleural Effusion. Medical Review, 25(19): 3844–3848.

Li W, Gao H, Chen H, et al., 2019, Clinical Significance of Serum Interleukin 33 and Soluble ST2 In Differential Diagnosis of Malignant Pleural Effusion and Tuberculous Pleural Effusion. Chinese Journal of Health Medicine, 21(04): 334–337.